Tumor Necrosis Factor News and Research

RSS
New Crohn's disease treatment Humira promises to reduce symptoms

New Crohn's disease treatment Humira promises to reduce symptoms

FDA approves Humira (adalimumab) for Crohn's disease

FDA approves Humira (adalimumab) for Crohn's disease

Study reveals white blood cells can both hurt and help transplanted kidneys

Study reveals white blood cells can both hurt and help transplanted kidneys

Detecting cancer with silica nanoparticles

Detecting cancer with silica nanoparticles

Drug infliximab may help ease ulcerative colitis

Drug infliximab may help ease ulcerative colitis

Tumor necrosis factor A antagonist use and cancer in patients with rheumatoid arthritis

Tumor necrosis factor A antagonist use and cancer in patients with rheumatoid arthritis

Central nervous system can sometimes send out signals that invite hostile immune system attacks

Central nervous system can sometimes send out signals that invite hostile immune system attacks

Arthritis drug wins approval for use in children with Crohn's disease

Arthritis drug wins approval for use in children with Crohn's disease

New rheumatoid arthritis drugs may put patients at risk of infections and cancer

New rheumatoid arthritis drugs may put patients at risk of infections and cancer

Study shows strong association between treatment with TNF-blocking antibodies and development of serious infections

Study shows strong association between treatment with TNF-blocking antibodies and development of serious infections

Etanercept and chemo might reduce fatigue in cancer patients

Etanercept and chemo might reduce fatigue in cancer patients

Study assesses formularies across Medicare drug plans

Study assesses formularies across Medicare drug plans

MIT look at how cells make life-or-death decisions

MIT look at how cells make life-or-death decisions

Ingredient in red peppers inhibits prostate cancer in laboratory studies

Ingredient in red peppers inhibits prostate cancer in laboratory studies

Thalidomide, Lenalidomide show promise against Lou Gehrig's disease

Thalidomide, Lenalidomide show promise against Lou Gehrig's disease

Attaching new cytokine to neural stem cells derived from bone marrow kills brain tumor cells

Attaching new cytokine to neural stem cells derived from bone marrow kills brain tumor cells

FDA approves Rituxan (Rituximab)

FDA approves Rituxan (Rituximab)

Link between rheumatoid arthritis and cancer examined

Link between rheumatoid arthritis and cancer examined

Study associates chronic, severe inflammation with increased lymphoma risk among RA patients

Study associates chronic, severe inflammation with increased lymphoma risk among RA patients

Protein levels predict bone marrow transplant survival

Protein levels predict bone marrow transplant survival